RT Journal Article SR Electronic T1 Canada-DONATE study protocol: a prospective national observational study of the medical management of deceased organ donors JF BMJ Open JO BMJ Open FD British Medical Journal Publishing Group SP e018858 DO 10.1136/bmjopen-2017-018858 VO 7 IS 9 A1 D’Aragon, Frederick A1 Dhanani, Sonny A1 Lamontagne, Francois A1 Cook, Deborah J A1 Burns, Karen A1 Akhtar, Aemal A1 Chassé, Michaël A1 Frenette, Anne-Julie A1 Keenan, Sean A1 Lize, Jean-Francois A1 Kutsogiannis, Demetrios J A1 Kramer, Andreas A1 Hand, Lori E A1 Arseneau, Erika A1 Masse, Marie-Helene A1 Ribic, Christine A1 Ball, Ian A1 Baker, Andrew A1 Boyd, Gordon A1 Rochwerg, Bram A1 Healey, Andrew A1 Hanna, Steven A1 Guyatt, Gordon H A1 Meade, Maureen O A1 YR 2017 UL http://bmjopen.bmj.com/content/7/9/e018858.abstract AB Introduction Research on the management of deceased organ donors aims to improve the number and quality of transplants and recipient outcomes. In Canada, this research is challenged by regionalisation of donation services within provinces and the geographical, clinical and administrative separation of donation from transplantation services. This study aims to build a national platform for future clinical trials in donor management. Objectives are to engage collaborators at donation hospitals and organ donation organisations (ODOs) across Canada, describe current practices, evaluate the effectiveness of donation-specific interventions and assess the feasibility of future clinical trials.Methods and analysis This ongoing prospective observational study of the medical management of deceased organ donors will enrol more than 650 consented potential donors from adult intensive care units at 33 hospital sites across Canada, each participating for 12 months. ODOs ensure enrolment of consecutive eligible participants. Research staff record detailed data about participants, therapies, organ assessments, death declaration procedures and adverse clinical exposures from the time of donation consent to organ recovery. ODOs provide reasons that organs are declined, dates and places of transplantation, and recipient age and sex.Descriptive analyses will summarise current practices. Effectiveness analyses will examine donation-specific interventions with respect to the number of transplants, using multilevel regression models to account for clustering by donor, hospitals and ODOs. Feasibility analyses will focus on acceptance of the research consent model; participation of academic and community hospitals as well as ODOs; and accessibility of recipient data.Ethics and dissemination This study uses a waiver of research consent. Hospitals will receive reports on local practices benchmarked to (1) national practices and (2) national donor management guidelines. We will report findings to donation and transplant collaborators (ie, clinicians, researchers, ODOs) and publish in peer-reviewed journals.Trial registration number NCT03114436.